Adapting immunity with subunit vaccines: Case studies with group A Streptococcus and malaria

International Journal for Parasitology

Volumn 32, Issue 5, 2002, Pages 575-580

  Good, Michael F ^a   Xu, Huji ^a   Batzloff, Michael ^a  

^a ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

Author keywords

Group A Streptococcus; Immunity; Malaria; Rheumatic fever; Vaccines

Indexed keywords

APICAL MEMBRANE ANTIGEN 1; MALARIA VACCINE; MEMBRANE ANTIGEN; MEROZOITE SURFACE PROTEIN 1; PROTEOME; STREPTOCOCCUS VACCINE; SUBUNIT VACCINE; UNCLASSIFIED DRUG;

MALARIA; VACCINATION;

BACTERIAL IMMUNITY; CONFERENCE PAPER; COST EFFECTIVENESS ANALYSIS; DRUG COST; DRUG DELIVERY SYSTEM; DRUG DESIGN; DRUG EFFICACY; EVOLUTION; IMMUNE RESPONSE; MALARIA; MORBIDITY; MORTALITY; NONHUMAN; PUBLIC HEALTH; SOCIOECONOMICS; STREPTOCOCCUS PYOGENES;

ANIMALS; DRUG DESIGN; HUMANS; IMMUNITY; MALARIA; MALARIA VACCINES; MICE; PLASMODIUM CHABAUDI; PLASMODIUM FALCIPARUM; STREPTOCOCCAL INFECTIONS; STREPTOCOCCAL VACCINES; STREPTOCOCCUS PYOGENES; VACCINES, SUBUNIT;

STREPTOCOCCUS; STREPTOCOCCUS PYOGENES; STREPTOCOCCUS SP. 'GROUP A';

EID: 0036208366     PISSN: 00207519     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0020-7519(01)00360-5     Document Type: Conference Paper

References (56)

1. Prolonged Th1-like response generated by a Plasmodium yoelii-specific T cell clone allows complete clearance of infection in reconstituted mice
2. A cryptic T cell epitope on the apical membrane antigen 1 of Plasmodium chabaudi adami can prime for an anamnestic antibody response: Implications for malaria vaccine design
3. Malaria vaccines
4. Cloning the P. falciparum gene encoding PfEMP1, a malarial variant antigen and adherence receptor on the surface of parasitized human erythrocytes
5. Synthetic peptide vaccine against mucosal colonization by group A streptococci. I. Protection against a heterologous M serotype with shared C repeat region epitopes
6. Antigenic variation in Plasmodium falciparum
7. Adoptive protection against Plasmodium chabaudi adami malaria in athymic nude mice by a cloned T cell line
8. Opsonic human antibodies from an endemic population specific for a conserved epitope on the M protein of group A streptococci
9. Protective and non-protective epitopes from the amino termini of M proteins from Australian Aboriginal isolates and reference strains of group A streptococci
10. New multi-determinant strategy for a group A streptococcal vaccine designed for the Australian Aboriginal population
11. Epitopes of group A streptococcal M protein that evoke cross-protective local immune responses
12. Recombinant, octavalent group A streptococcal M protein vaccine
13. Humoral response to a carboxyl-terminal region of the merozoite surface protein-1 plays a predominant role in controlling blood-stage infection in rodent malaria
14. Assessment of a vaccinia virus vectored multi-epitope live vaccine candidate for Plasmodium falciparum
15. The complexity of protective immunity against liver-stage malaria
16. DNA-based vaccines against malaria: Status and promise of the multi-stage malaria DNA vaccine operation
17. Malaria vaccine development: Current status
18. Protection of rats against malaria by a transplanted immune spleen
19. Vaccine development for group A streptococcal infections
20. Safety and immunogenicity of a three-component blood-stage malaria vaccine in adults living in an endemic area of Papua New Guinea
21. Towards a blood-stage vaccine for malaria: Are we following all the leads?
22. Immune effector mechanisms in malaria
23. Pathways and strategies for developing a malaria blood-stage vaccine
24. Vaccine control strategies against group A streptococcal infections: Expectations, hopes and possible impact
25. Antibody-independent immunity to reinfection malaria in B-cell-deficient mice
26. Protective immune response against Streptococcus pyogenes in mice after intranasal vaccination with the fibronectin-binding protein SfbI
27. Mapping the minimal murine T cell and B cell epitopes within a peptide vaccine candidate from the conserved region of the M protein of group A streptococcus
28. + T cells adoptively transferred into recipient mice after challenge with homologous parasite
29. + T cells
30. 19) induces protective immunity to blood stage malaria infection in mice
31. Complete nucleotide sequence of type 6 M protein of the group A streptococcus. Repetitive structure and membrane anchor
32. Free radical induced polymerization of synthetic peptides into polymeric immunogens
33. Intranasal immunisation with C5a peptidase prevents nasopharyngeal colonization of mice by the group A Streptococcus
34. Sequence conservation in the C-terminal part of the precursor to the major merozoite surface proteins (MSP1) of Plasmodium falciparum from field isolates
35. Transmission-blocking vaccines: Uses and current status of development
36. Immunisation against malaria with a recombinant protein
37. Proteosomes for improved nasal, oral, or injectable vaccines
38. Interferon-gamma responses are associated with resistance to reinfection with Plasmodium falciparum in young African children
39. Antigens induced on erythrocytes by P. falciparum: Expression of diverse and conserved determinants
40. Analysis of sequence diversity in the Plasmodium falciparum merozoite surface protein-1 (MSP-1)
41. Polymerization of unprotected synthetic peptides: A view towards synthetic peptide vaccines
42. Conserved T and B cell epitopes on the M protein of group A streptococci - Induction of bactericidal antibodies
43. Towards a vaccine for rheumatic fever: Identification of a conserved target epitope on the M protein of group A streptococci
44. Identification of T-cell autoepitopes that cross-react with the C-terminal segment of the M protein of group A Streptococci
45. Mapping a conserved conformational epitope from the M protein of group A streptococci
46. Switches in expression of Plasmodium falciparum var genes correlate with changes in antigenic and cytoadherent phenotypes of infected erythrocytes
47. IL-12-induced protection against blood-stage Plasmodium chabaudi AS requires IFN-gamma and TNF-alpha and occurs via a nitric oxide-dependent mechanism
48. The large diverse gene family var encodes proteins involved in cytoadherence and antigenic variation of Plasmodium falciparum-infected erythrocytes
49. Central role of endogenous gamma interferon in protective immunity against blood-stage Plasmodium chabaudi AS infection
50. H2 cells in a rodent malaria infection
51. Inhibitory and blocking monoclonal antibody epitopes on merozoite surface protein 1 of the malaria parasite Plasmodium falciparum
52. The resolution of acute malaria in a definitive model of B cell deficiency, the JHD mouse
53. Gene-targeted mice lacking B cells are unable to eliminate a blood stage malaria infection
54. 19) during malaria infection
55. + T cells acting independently of antibody contribute to protective immunity to Plasmodium chabaudi infection after apical membrane antigen 1 immunisation